BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2855385)

  • 1. Localization and pharmacology of some dopamine receptor complexes in the striatum and the pituitary gland: synaptic and son-synaptic communication.
    Stoof JC
    Acta Morphol Neerl Scand; 1988-1989; 26(2-3):115-30. PubMed ID: 2855385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of lithium treatment on the activity of central dopaminergic neurons].
    Koyama T
    Hokkaido Igaku Zasshi; 1987 May; 62(3):402-16. PubMed ID: 3111963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic and non-synaptic striatal dopamine D2 receptors: possible implications in normal and pathological behaviour.
    Korf J; Loopuijt LD
    Acta Morphol Neerl Scand; 1988-1989; 26(2-3):177-90. PubMed ID: 2908162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.
    Goudreau JL; Manzanares J; Lookingland KJ; Moore KE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):303-7. PubMed ID: 8386238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum.
    Consolo S; Wu CF; Fusi R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical investigation of nuclear progestin receptor expression within dopaminergic neurones of the female rat brain.
    Lonstein JS; Blaustein JD
    J Neuroendocrinol; 2004 Jun; 16(6):534-43. PubMed ID: 15189328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
    Miller AD; Forster GL; Yeomans JS; Blaha CD
    Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
    Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
    J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on aging processes.
    Agnati LF; Fuxe K; Benfenati F; Toffano G; Cimino M; Battistini N; Calza L; Merlo Pich E
    Acta Physiol Scand Suppl; 1984; 532():45-61. PubMed ID: 6093434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
    Schotanus SM; Chergui K
    J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
    Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
    J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of altered function of dopaminergic neurones on the cholinergic system in the striatum.
    Ladinsky H; Consolo S
    Prog Brain Res; 1979; 49():411-9. PubMed ID: 229517
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the dopaminergic tubero-hypophysial neurones in the maintenance of 'basal' melanocyte-stimulating hormone levels in the rat [proceedings].
    Penny RJ; Tilders FJ; Thody AJ
    J Endocrinol; 1979 Feb; 80(2):58P-59P. PubMed ID: 220369
    [No Abstract]   [Full Text] [Related]  

  • 18. Two dopamine receptors: biochemistry, physiology and pharmacology.
    Stoof JC; Kebabian JW
    Life Sci; 1984 Dec; 35(23):2281-96. PubMed ID: 6390056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine autoreceptor agonist, (+/-)-trans-1,3,4,4a5,10b-hexahydro-4-propyl-2H [1]benzopyrano [3,4-b] pyridin-9-ol hydrochloride (CGS 15855A), modulates striatal dopamine metabolism and prolactin release.
    Iyengar S; Hausler A; Kim HS; Marien M; Altar CA; Wood PL
    Neuropharmacology; 1989 Jan; 28(1):27-31. PubMed ID: 2522597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-dependent tuning of striatal inhibitory synaptogenesis.
    Goffin D; Ali AB; Rampersaud N; Harkavyi A; Fuchs C; Whitton PS; Nairn AC; Jovanovic JN
    J Neurosci; 2010 Feb; 30(8):2935-50. PubMed ID: 20181591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.